Intravitreally injected ranibizumab versus photodynamic therapy for CNV secondary to choroidal osteoma: a 7-year follow-up case report

doi:10.18240/ijo.2021.06.22

Home > Archive>Volume 14, Issue 6, 2021 >940-944. DOI:10.18240/ijo.2021.06.22

Intravitreally injected ranibizumab versus photodynamic therapy for CNV secondary to choroidal osteoma: a 7-year follow-up case report
DOI:
                        10.18240/ijo.2021.06.22
                    
Author:
                        
                        
                    
Contact Author:Shi-Ying Li. Department of Ophthalmology, Xiang’an Hospital of Xiamen University; Medical Center of Xiamen University; School of Medicine, Xiamen University, Xiamen 361102, Fujian Province, China. shiying_li@126.com
Affiliation:
Clc Number:
Fund Project:Supported by the National Nature Science Foundation of China (No.81974138); National Basic Research Program of China (No.2018YFA0107301); Chongqing Social and Livelihood Science Innovation Grant (No.cstc2017shmsA130100).

Article

Figures

Metrics

Reference

Cited by

Materials

Comments

Abstract:

Reference

Cited by

Get Citation

Li-Yuan Rong, Li Ran, Shi-Ying Li, et al. Intravitreally injected ranibizumab versus photodynamic therapy for CNV secondary to choroidal osteoma: a 7-year follow-up case report. Int J Ophthalmol, 2021,14(6):940-944

Copy

Article Metrics

Abstract:
PDF:
HTML:
Cited by:

History

Received:August 13,2020
Revised:October 30,2020
Adopted:
Online: April 23,2021
Published:

Home

Articles

Journal Info

For Authors

For Reviewers

Publication Policies

News and Events

RSS

Get Citation

Share

Article Metrics

History